MIF and breast carcinoma: This regulatory dichotomy extends beyond hepatic systems, as evidenced by breast cancer studies showing that macrophage migration inhibitory factor (MIF)-mediated Cav-1 phosphorylation modulates CD11b+ immune cell recruitment [30].